Q2 2026 Earnings Call February 4, 2026 9:00 AM ESTCompany ParticipantsDavid Clair - VP of Investor Relations & ...
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that PharosAI, a research consortium uniting four leading UK institutions, will use the 10x Genomics Xenium ...
Making diagrams saves time, reduces ambiguity, and leaves a memorable impression on examiners. Check tips shared by the ...
When sudden, excruciating abdominal pain revealed a rare and aggressive blood cancer, Ted Wagstaff faced his toughest ...
Since 2017, PHYS 0040: “Basic Physics B” has often been taught in Barus and Holley 166, the classroom where the mass shooting ...
What a punk rock frontman with a Ph.D. reveals about breaking career rules, rejecting linear paths and why nonlinear careers ...
Researchers in Class of 1942 Professor of Chemistry Matthew D. Shoulders' lab have uncovered a sinister hidden mechanism that ...
Issued Claims Protect Distinct Molecular Designs with Broad Therapeutic Potential Across Inflammatory, Fibrotic, and ...
Hidden inside the human body, scientists have uncovered thousands of bizarre RNA loops unlike anything in biology. These ...
LEQEMBI is currently approved in 53 countries and regions and is under regulatory review in 7 countries. In August 2025, the US FDA approved LEQEMBI IQLIK 360 mg for weekly subcutaneous maintenance ...
If approved, LEQEMBI IQLIK would be the first and only anti-amyloid treatment to offer at-home injection options for initiation and maintenance dosing for this progressive, relentless disease ...
The cancer gene MYC camouflages tumors by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a promising way to improve existing cancer therapies ...